News

ONCOLife presents an exclusive interview with Dr. Miguel-Angel Perales, Co-Chair of the CAR T Vision initiative, as he shares ...
We’re honored to share our exclusive interview with Lorna Warick, CEO of Lymphoma Coalition. In this session, we explore the ...
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...
Vividion Therapeutics, a clinical-stage biopharmaceutical company and an independently operated subsidiary of Bayer AG, is further reinforcing its oncology pipeline with the clinical-stage Werner ...
In a significant development for the treatment of extensive-stage small cell lung cancer (ES-SCLC), the Phase III IMforte study has shown that the combination of Roche’s Tecentriq® (atezolizumab) with ...
Bayer announced new post-hoc analyses from the Phase III ARANOTE trial, showing that darolutamide (Nubeqa) plus androgen deprivation therapy (ADT) improved health-related quality of life (HRQoL) and ...
START already boasts an unparalleled track record in early-phase oncology trials, having supported over 1,000 studies, including those that led to 45 FDA or EMA approvals. With ten clinical trial ...
The new data from the PERSEUS and CEPHEUS studies show that DARZALEX FASPRO®-based regimens achieve up to 95% 4-year PFS and over 55% sustained MRD negativity in transplant-eligible patients, and 69% ...
Zai Lab presented updated Phase 1 data for ZL-1310, an investigational DLL3-targeted antibody-drug conjugate (ADC) for heavily pretreated patients with extensive-stage small cell lung cancer (ES-SCLC) ...
The Phase 3 AMPLITUDE trial showed that adding niraparib to abiraterone acetate and prednisone reduced radiographic progression or death by 37% in patients with metastatic castration-sensitive ...
bioXcelerate has unveiled the bioX Genetics Platform, which cuts the time needed to detect genetic variants by 98% and achieves 99% accuracy, leveraging AI-driven tools to accelerate drug discovery.